Ligand Pharmaceuticals Incorporated
Head Quarters
Suite 110 3911 Sorrento Valley Boulevard USWebsite
http://www.ligand.comIndustry
BiotechnologyEmployees
22Exchange
NASDAQLigand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 0 |
| Gross Margin (%) | 0.85% |
| Net Margin (%) | 0.05% |
| Returns | Stock |
| Sales | $108.00M |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | $24.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 66.88 |
| EPS | $0.00 |